TradingKey - Eli Lilly (LLY) shares rose nearly 2% in Thursday’s pre-market session as the market focused on a major decision from U.S. healthcare giant CVS Health (CVS). CVS announced it would restore insurance coverage for the weight-loss drug Zepbound and include Foundayo, an oral weight-loss medication newly approved in April, in its standard drug formulary.

TradingKeyThu, May 28

Telemedicine and Telehealth Stocks to Watch in 2026

TradingKey - The healthcare system was one of the first industries to go through a major transformation; now, investors are watching closely. Every day, we see new technology being created for diagnosing and treating diseases. The method of delivery in allowing patients access to care has changed al

TradingKeyMon, Feb 23

CVS Health 2.0: Leaner, Smarter, Stronger

TradingKey - In the midst of a chaotic healthcare environment of price scrutiny, margin pressure, and shifting consumer behavior, CVS Health (CVS) has undertaken a conscious shift: less bulk, more acuity.

TradingKeyMay 16, 2025